All entries for: ODDIFACT SAS
March 24, 2026
ODDIFACT SAS
Orphan Drug Designation
treatment of myelin oligodendrocyte glycoprotein antibody-associated disease
Disease Area: Rare Diseases
treatment of chronic graft-versus-host disease
treatment of myelin oligodendrocyte glycoprotein antibody-associated disease